2009 update in salivary gland tumoral pathology;Tumeurs des glandes salivaires. État des lieux en 2009

Annales de Pathologie

Volumn 29, Issue 4, 2009, Pages 274-285

  Uro Coste, Emmanuelle ^a  

^a CHU RANGUEIL   (France)

Author keywords

Anaplastic transformation; Carcinoma; Grading; Mucoepidermoid; Pleomorphic adenoma; Salivary glands tumors; Translocation

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; HIGH MOBILITY GROUP A2 PROTEIN; KI 67 ANTIGEN; MASPIN; PROTEIN KINASE B; PROTEIN P27; PROTEIN PLAG1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; ADENOSQUAMOUS CARCINOMA; ANAPLASTIC CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RELAPSE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME PHOSPHORYLATION; EOSINOPHILIA; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOMA; LYMPHEDEMA; MALIGNANT TRANSFORMATION; MINOR SALIVA GLAND; PLEOMORPHIC ADENOMA; PROGNOSIS; PROTEIN TARGETING; SALIVARY GLAND CANCER; SALIVARY GLAND CARCINOMA; SALIVARY GLAND TUMOR; SHORT SURVEY; TONGUE CARCINOMA; ARTICLE; CARCINOMA; CLASSIFICATION; PATHOLOGY;

CARCINOMA; HUMANS; SALIVARY GLAND NEOPLASMS;

EID: 70350716309     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2009.07.002     Document Type: Short Survey

References (55)

1. Pathology and genetics of head and neck tumours. In: Barnes E.L., Eveson J.W., Reichart P., and Sidransky D (Eds). World Health Organization classification of tumours (2005), IARC Press, Lyon
2. AFIP Atlas of tumor pathology. In: Ellis G.L., Auclair P.L., Silverberg S.G., and Sobin L.H. (Eds). Tumors of the salivary glands The american registry of Pathology Washington DC. (2008), ARP Press, Silver spring Maryland
3. AJCC cancer staging manual. 6th ed. New York, NY: Springer; 2002.
4. Edwards P.C., Bhuiya T., and Kelsch R.D. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 586-593
5. Schroeder U., Groppe D., Mueller R.P., and Guntinas-Lichius O. Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction. Cancer 113 (2008) 758-764
6. Behboudi A., Enlund F., Winnes M., et al. Molecular classification of mucoepidermoid carcinomas - prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45 (2006) 470-481
7. Seethala R.R. An update on grading of salivary gland carcinomas. Head Neck Pathol 69 (2009) 69-77
8. Cheuk W., and Chan J.K. Advances in salivary gland pathology. Histopathology 51 (2007) 1-20
9. Luukkaa H., Klemi P., Leivo I., Vahlberg T., and Grénman R. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases. Acta Oncol 45 (2006) 669-675
10. Kas K., Voz M.L., Roijer E., et al. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 15 (1997) 170-174
11. Voz M.L., Agten N.S., Van de Ven W.J., and Kas K. PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 60 (2000) 106-113
12. Voz M.L., Astrom A.K., Kas K., Mark J., Stenman G., and Van de Ven W.J. The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter. Oncogene 16 (1998) 1409-1416
13. Astrom A.K., Voz M.L., Kas K., et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res 59 (1999) 918-923
14. Asp J., Persson F., Kost-Alimova M., and Stenman G. CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas. Genes Chromosomes Cancer 45 (2006) 820-828
15. El-Naggar A.K., Callender D., Coombes M.M., Hurr K., Luna M.A., and Batsakis J.G. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?. Genes Chromosomes Cancer 27 (2000) 162-168
16. Rao P.H., Murty V.V., Louie D.C., and Chaganti R.S. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. Cancer Genet Cytogenet 105 (1998) 160-163
17. Roijer E., Nordkvist A., Strom A.K., et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 160 (2002) 433-440
18. Di Palma S., Skalova A., Vanieek T., Simpson R.H., Starek I., and Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology 46 (2005) 144-152
19. Tonon G., Modi S., Wu L., et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33 (2003) 208-213
20. Goode R.K., Auclair P.L., and Ellis G.L. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 82 (1998) 1217-1224
21. Brandwein M., Huvos A.G., Dardick I., Thomas M.J., and Theise N.D. Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (1996) 655-664
22. Skalova A., Lehtonen H., von Boguslawsky K., and Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25 9 (1994) 929-935
23. Lennerz J.K.M., Perry A., Mills J.C., Huettner P.C., and Pfeifer J.D. Mucoepidermoid carcinoma of the Cervix Another Tumor With the t(11;19)-associated CRTC1-MAML2Gene Fusion. Am J Surg Pathol 33 (2009) 835-843
24. Serra A., Schackert H.K., Mohr B., Weise A., Liehr T., and Fitze G. t(11;19)(q21;p12∼p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma. J Pediatr Surg 42 (2007) 23-29
25. Bullerdiek J., Haubrich J., Meyer K., and Bartnitzke S. Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet 35 (1988) 129-132
26. Martins C., Cavaco B., Tonon G., Kaye F.J., Soares J., and Fonseca I. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn 6 (2004) 205-210
27. Brannon R.B., and Willard C.C. Oncocytic mucoepidermoid carcinoma of parotid gland origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 727-733
28. Urano M., Abe M., Horibe Y., Kuroda M., Mizoguchi Y., Sakurai K., et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary glands. Pathol Res Pract 198 (2002) 305-310
29. Skalova A., Leivo I., Von Boguslawsky K., and Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol 173 (1994) 13-21
30. Frierson Jr. H.F., El-Naggar A.K., Welsh J.B., Sapinoso L.M., Su A.I., Cheng J., et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161 (2002) 1315-1323
31. Stallmach I., Zenklusen P., Komminoth P., Schmid S., Perren A., Roos M., et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 440 (2002) 77-84
32. Norberg-Spaak L., Dardick I., and Ledin T. Adenoid cystic carcinoma: use of cell proliferation, BCL-2 expression, histologic grade, and clinical stage as predictors of clinical outcome. Head Neck 22 5 (2000) 489-497
33. Nordgård S., Franzén G., Boysen M., and Halvorsen T.B. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections. Laryngoscope 107 4 (1997) 531-536
34. Hotte S.J., Winquist E.W., Lamont E., et al. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study. J Clin Oncol 23 (2005) 585-590
35. Smith B.C., Ellis G.L., Slater L.J., and Foss R.D. Sclerosing polycystic adenosis of major salivary glands. A clinicopathologic analysis of nine cases. Am J Surg Pathol 20 (1996) 161-170
36. Gnepp D.R. Sclerosing polycystic adenosis of the salivary gland: a lesion that may be associated with dysplasia and carcinoma in situ. Adv Anat Pathol 10 (2003) 218-222
37. Gnepp D.R., Wang L.J., Brandwein-Gensler M., Slootweg P., Gill M., and Hille J. Sclerosing polycystic adenosis of the salivary gland: a report of 16 cases. Am J Surg Pathol 30 (2006) 154-164
38. Ma J., Chan J.K., Chow C.W., and Orell S.R. Lymphadenoma: a report of three cases of an uncommon salivary gland neoplasm. Histopathology 41 (2002) 342-350
39. Jang Y.W., Kim S.G., Pai H., Park J.W., Lee Y.C., and Rotaru H. Sialolipoma: case report and review of 27 cases. Oral Maxillofac Surg 13 (2009) 109-113
40. Seethala R.R., Richmond J.A., Hoschar A.P., and Barnes E.L. New variants of epithelial-myoepithelial carcinoma: oncocytic-sebaceous and apocrine. Arch Pathol Lab Med 133 (2009) 950-959
41. Michal M., Skálová A., Simpson R.H., Raslan W.F., Curík R., Leivo I., et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 35 (1999) 495-501
42. Uro-Coste E. Particularité des tumeurs des glandes salivaires accessoires. Ann Pathol 27 (2007) 1S76-11S
43. Ghannoum J.E., and Freedman P.D. Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands. Am J Surg Pathol 28 (2004) 89-93
44. Ide F., Mishima K., Tanaka A., Saito I., and Kusama K. Mucinous adenocarcinoma of minor salivary glands: a high-grade malignancy prone to lymph node metastasis. Virchows Arch 454 (2009) 55-60
45. Ettl T., Schwarz S., Kleinsasser N., Hartmann A., Reichert T.E., and Driemel O. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Histopathology 53 (2008) 567-577
46. Vidal L., Tsao M.S., Pond G.R., Cohen E.E., Cohen R.B., Chen E.X., et al. Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib. Head Neck (2009)
47. Volker H.U., Scheich M., Berndt A., Haubitz I., Metzger A., Muller-Hermelink H.K., et al. Expression of p-AKT characterizes adenoid cystic carcinomas of head and neck with a higher risk for tumor relapses. Diagn Pathol 4 (2009) 18
48. Maruya S., Shirasaki T., Nagaki T., Kakehata S., Kurotaki H., Mizukami H., et al. Differential expression of topoisomerase IIalpha protein in salivary gland carcinomas: histogenetic and prognostic implications. BMC Cancer 9 (2009) 72
49. Miyabe S., Okabe M., Nagatsuka H., Hasegawa Y., Inagaki A., Ijichi K., et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. J Oral Maxillofac Surg 67 (2009) 1432-1441
50. Nagler R.M., Ben-Izhak O., Ostrovsky D., Golz A., and Hershko D.D. The expression and prognostic significance of Cks1 in salivary cancer. Cancer Invest 27 (2009) 512-520
51. Nikitakis N.G., Scheper M.A., Papanikolaou V.S., and Sauk J.J. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 (2009) 826-836
52. Schwarz S., Ettl T., Kleinsasser N., Hartmann A., Reichert T.E., and Driemel O. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Oral Oncol 44 (2008) 563-570
53. Vered M., Allon I., Buchner A., and Dayan D. Is maspin immunolocalization a tool to differentiate central low-grade mucoepidermoid carcinoma from glandular odontogenic cyst?. Acta Histochem (2009) 10.1016/j.acthis.2008.10.006
54. Zhang X., Cairns M., Rose B., O'Brien C., Shannon K., Clark J., et al. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 124 (2009) 2855-2863
55. Skalova A., Gnepp D.R., Simpson R.H., et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol 30 (2006) 939-944